Nerve growth factor, brain-derived neurotrophic factor, and the chronobiology of mood: a new insight into the "neurotrophic hypothesis"

References

• Albrecht U. Timing to perfection: the biology of central and peripheral circadian clocks. Neuron. 2012;74(2):246–260.
   PubMed Web of Science ®Google Scholar
• Czeisler CA, Buxton OM, Khalsa SB. The human circadian timing system and sleep-wake regulation. In: Kryger MH, Roth T, Dement WC, editors. Principles and Practice of Sleep Medicine. 4th ed. Philadelphia, PA: Elsevier/Saunders; 2005:375–394.
   Google Scholar
• Herzog ED. Neurons and networks in daily rhythms. Nat Rev Neurosci. 2007;8(10):790–802.
   PubMed Web of Science ®Google Scholar
• Ueyama T, Krout KE, Nguyen XV, et al. Suprachiasmatic nucleus: a central autonomic clock. Nat Neurosci. 1999;2(12):1051–1053.
   PubMed Web of Science ®Google Scholar
• Hattar S, Liao HW, Takao M, Berson DM, Yao KW. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science. 2002;295(8):1065–1068.
   Google Scholar
• Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295(8):1069.
   Google Scholar
• Hatori M, Panda S. The emerging roles of melanopsin in behavioral adaptation to light. Trends Mol Med. 2010;16(10):435–446.
   PubMed Web of Science ®Google Scholar
• Cui Q, Ren C, Sollars PJ, Pickard GE, So KF. The injury resistant ability of melanopsin-expressing intrinsically photosensitive retinal ganglion cells. Neuroscience. 2015;284:845–853.
   PubMed Web of Science ®Google Scholar
• Vandewalle G, Collignon O, Hull JT, et al. Blue light stimulates cognitive brain activity in visually blind individuals. J Cogn Neurosci. 2013; 25(12):2072–2085.
   PubMed Web of Science ®Google Scholar
• Vandewalle G, Maquet P, Dijk DJ. Light as a modulator of cognitive brain function. Trends Cogn Sci. 2009;13(10):429–438.
   PubMed Web of Science ®Google Scholar
• Morin LP. Neuroanatomy of the extended circadian rhythm system. Exp Neurol. 2013;243:4–20.
   Web of Science ®Google Scholar
• Teng HK, Teng KK, Lee R, et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci. 2005;25(22):5455–5463.
   PubMed Web of Science ®Google Scholar
• Elliott AS, Weiss ML, Nunez AA. Direct retinal communication with the peri-amygdaloid area. Neuroreport. 1995;6(5):806–808.
   Web of Science ®Google Scholar
• Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. A neural circuit for circadian regulation of arousal. Nat Neurosci. 2001;4(7):732–738.
   PubMed Web of Science ®Google Scholar
• Vandewalle G, Schmidt C, Albouy G, et al. Brain responses to violet, blue, and green monochromatic light exposures in humans: prominent role of blue light and the brainstem. PLoS One. 2007;2(11):e1247.
   Web of Science ®Google Scholar
• Iannitelli A, Tirassa P. . Pain and Depression: the Janus Factor of Human Suffering. In: Battaglia A, editor. Introduction to pain and its relations to nervous system disorders. New York: Wiley-Blackwell: 2015.
   Google Scholar
• Borsook D, Becerra L, Carlezon WA Jr, et al. Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders. Eur J Pain. 2007;11(1):7–20.
   Web of Science ®Google Scholar
• Navratilova E, Xie JY, Okun A, et al. Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry. Proc Natl Acad Sci U S A. 2012;109(50):20709–20713.
   Web of Science ®Google Scholar
• Sleipness EP, Sorg BA, Jansen HT. Diurnal differences in dopamine transporter and tyrosine hydroxylase levels in rat brain: dependence on the suprachiasmatic nucleus. Brain Res. 2007;1129(1):34–42.
   PubMed Web of Science ®Google Scholar
• Hampp G, Ripperger JA, Houben T, et al. Regulation of monoamine oxidase A by circadian-clock components implies clock influence on mood. Curr Biol. 2008;18(9):678–683.
   PubMed Web of Science ®Google Scholar
• Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987;237(4819):1154–1162.
   PubMed Web of Science ®Google Scholar
• Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 2001;24:1217–1281.
   PubMed Web of Science ®Google Scholar
• Aloe L, Alleva E, Fiore M. Stress and nerve growth factor: findings in animal models and humans. Pharmacol Biochem Behav. 2002;73(1):159–166.
   Web of Science ®Google Scholar
• Cirulli F, Laviola G, Ricceri L. Risk factors for mental health: translational models from behavioural neuroscience. Neurosci Biobehav Rev. 2009;33(4):493–497.
   Web of Science ®Google Scholar
• Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4(4):299–309.
   PubMed Web of Science ®Google Scholar
• Chen LW, Yung KK, Chan YS, Shum DK, Bolam JP. The proNGF-p75NTR-sortilin signalling complex as new target for the therapeutic treatment of Parkinson’s disease. CNS Neurol Disord Drug Targets. 2008;7(6):512–523.
   Web of Science ®Google Scholar
• Cuello AC, Bruno MA, Allard S, Leon W, Iulita MF. Cholinergic involvement in Alzheimer’s disease. A link with NGF maturation and degradation. J Mol Neurosci. 2010;40(1–2):230–235.
   Web of Science ®Google Scholar
• Tirassa P, Maccarone M, Florenzano F, Cartolano S, De Nicolo S. Vascular and neuronal protection induced by the ocular administration of nerve growth factor in diabetic-induced rat encephalopathy. CNS Neurosci Ther. 2013;19(5):307–318.
   PubMed Web of Science ®Google Scholar
• Lessmann V, Gottmann K, Malcangio M. Neurotrophin secretion: current facts and future prospects. Prog Neurobiol. 2003;69(5):341–374.
   PubMed Web of Science ®Google Scholar
• Castren E. Neurotrophins as mediators of drug effects on mood, addiction, and neuroprotection. Mol Neurobiol. 2004;29(3):289–302.
   PubMed Web of Science ®Google Scholar
• Tirassa P, Maccarone M, Carito V, De Nicolo S, Fiore M. Ocular nerve growth factor administration counteracts the impairment of neural precursor cell viability and differentiation in the brain subventricular area of rats with streptozotocin-induced diabetes. Eur J Neurosci. 2015;41(9):1207–1218.
   Web of Science ®Google Scholar
• Lambiase A, Tirassa P, Micera A, Aloe L, Bonini S. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest Ophthalmol Vis Sci. 2005;46(10):3800–3806.
   PubMed Web of Science ®Google Scholar
• Canossa M, Griesbeck O, Berninger B, Campana G, Kolbeck R, Thoenen H. Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity. Proc Natl Acad Sci U S A. 1997;94(24):13279–13286.
   Web of Science ®Google Scholar
• Kruttgen A, Moller JC, Heymach JV Jr, Shooter EM. Neurotrophins induce release of neurotrophins by the regulated secretory pathway. Proc Natl Acad Sci U S A. 1998;95(16):9614–9619.
   Web of Science ®Google Scholar
• Berardi N, Maffei L. From visual experience to visual function: roles of neurotrophins. J Neurobiol. 1999;41(1):119–126.
   Google Scholar
• von Bartheld CS. Neurotrophins in the developing and regenerating visual system. Histol Histopathol. 1998;13(2):437–459.
   PubMed Web of Science ®Google Scholar
• Carmignoto G, Comelli MC, Candeo P, et al. Expression of NGF receptor and NGF receptor mRNA in the developing and adult rat retina. Exp Neurol. 1991;111(3):302–311.
   PubMed Web of Science ®Google Scholar
• Wahle P, Di Cristo G, Schwerdtfeger G, Engelhardt M, Berardi N, Maffei L. Differential effects of cortical neurotrophic factors on development of lateral geniculate nucleus and superior colliculus neurons: anterograde and retrograde actions. Development. 2003;130(3):611–622.
   Web of Science ®Google Scholar
• Butowt R, von Bartheld CS. Sorting of internalized neurotrophins into an endocytic transcytosis pathway via the Golgi system: ultrastructural analysis in retinal ganglion cells. J Neurosci. 2001;21(22):8915–8930.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Moheban DB, Conway BR, Bhattacharyya A, Segal RA. Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation. J Neurosci. 2000;20(15):5671–5678.
   PubMed Web of Science ®Google Scholar
• Ojeda SR, Hill DF, Katz KH. The genes encoding nerve growth factor and its receptor are expressed in the developing female rat hypothalamus. Brain Res Mol Brain Res. 1991;9(1–2):47–55.
   Google Scholar
• Liang FQ, Sohrabji F, Miranda R, Earnest B, Earnest D. Expression of brain-derived neurotrolphic factor and its cognate receptor, TrkB, in the rat suprachiasmatic nucleus. Exp Neurol. 1998;151(2):184–193.
   Web of Science ®Google Scholar
• Bina KG, Rusak B. Nerve growth factor phase shifts circadian activity rhythms in Syrian hamsters. Neurosci Lett. 1996;206(2–3):97–100.
   Web of Science ®Google Scholar
• Pizzio GA, Hainich EC, Plano SA, Ralph MR, Golombek DA. Nerve growth factor-induced circadian phase shifts and MAP kinase activation in the hamster suprachiasmatic nuclei. Eur J Neurosci. 2005;22(3):665–671.
   Web of Science ®Google Scholar
• Liang FQ, Allen G, Earnest D. Role of brain-derived neurotrophic factor in the circadian regulation of the suprachiasmatic pacemaker by light. J Neurosci. 2000;20(8):2978–2987.
   Web of Science ®Google Scholar
• Sofroniew MV, Isacson O, O’Brien TS. Nerve growth factor receptor immunoreactivity in the rat suprachiasmatic nucleus. Brain Res. 1989;476(2):358–362.
   Web of Science ®Google Scholar
• Kiss J, Patel AJ, Halasz B. Colocalization of NGF receptor with VIP in rat suprachiasmatic neurones. Neuroreport. 1993;4(12):1315–1318.
   Web of Science ®Google Scholar
• Golombek DA, Ralph MR. Let there be light: signal transduction in a mammalian circadian system. Braz J Med Biol Res. 1996;29(1):131–140.
   Web of Science ®Google Scholar
• Beaule C, Amir S. Effect of 192 IgG-saporin on circadian activity rhythms, expression of P75 neurotrophin receptors, calbindin-D28K, and light-induced Fos in the suprachiasmatic nucleus in rats. Exp Neurol. 2002;176(2):377–389.
   Web of Science ®Google Scholar
• Erhardt C, Galani R, Jeltsch H, et al. Modulation of photic resetting in rats by lesions of projections to the suprachiasmatic nuclei expressing p75 neurotrophin receptor. Eur J Neurosci. 2004;19(7):1773–1788.
   Web of Science ®Google Scholar
• Paula-Barbosa MM, Silva SM, Andrade JP, Cadete-Leite A, Madeira MD. Nerve growth factor restores mRNA levels and the expression of neuropeptides in the suprachiasmatic nucleus of rats submitted to chronic ethanol treatment and withdrawal. J Neurocytol. 2001;30(3):195–207.
   Google Scholar
• Pereira PA, Cardoso A, Paula-Barbosa MM. Nerve growth factor restores the expression of vasopressin and vasoactive intestinal polypeptide in the suprachiasmatic nucleus of aged rats. Brain Res. 2005; 1048(1–2):123–130.
   Web of Science ®Google Scholar
• Sala R, Viegi A, Rossi FM, et al. Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex. Eur J Neurosci. 1998;10(6):2185–2191.
   Web of Science ®Google Scholar
• Hannibal J. Neurotransmitters of the retino-hypothalamic tract. Cell Tissue Res. 2002;309(1):73–88.
   PubMed Web of Science ®Google Scholar
• Michel S, Clark JP, Ding JM, Colwell CS. Brain-derived neurotrophic factor and neurotrophin receptors modulate glutamate-induced phase shifts of the suprachiasmatic nucleus. Eur J Neurosci. 2006;24(4):1109–1116.
   PubMed Web of Science ®Google Scholar
• Hempstead BL, Martin-Zanca D, Kaplan DR, Parada LF, Chao MV. High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature. 1991;350(6320):678–683.
   PubMed Web of Science ®Google Scholar
• Baeza-Raja B, Eckel-Mahan K, Zhang L, et al. p75 neurotrophin receptor is a clock gene that regulates oscillatory components of circadian and metabolic networks. J Neurosci. 2013;33(25):10221–10234.
   Web of Science ®Google Scholar
• Tirassa P, Iannitelli A, Sornelli F, et al. Daily serum and salivary BDNF levels correlate with morning-evening personality type in women and are affected by light therapy. Riv Psichiatr. 2012;47(6):527–534.
   Web of Science ®Google Scholar
• Sposato V, Parisi V, Manni L, et al. Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application. Vision Res. 2009;49(1):54–63.
   Web of Science ®Google Scholar
• Tirassa P. The nerve growth factor administrated as eye drops activates mature and precursor cells in subventricular zone of adult rats. Arch Ital Biol. 2011;149(2):205–213.
   Web of Science ®Google Scholar
• Di Fausto V, Fiore M, Tirassa P, Lambiase A, Aloe L. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Eur J Neurosci. 2007;26(9):2473–2480.
   PubMed Web of Science ®Google Scholar
• Fiore M, Angelucci F, Aloe L, Iannitelli A, Korf J. Nerve growth factor and brain-derived neurotrophic factor in schizophrenia and depression: findings in humans and in animal models. Curr Neuropharmacol. 2003;1:1–20.
   Google Scholar
• Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59(12):1116–1127.
   PubMed Web of Science ®Google Scholar
• Bersani G, Iannitelli A, Maselli P, et al. Low nerve growth factor plasma levels in schizophrenic patients: a preliminary study. Schizophr Res. 1999;37(2):201–203.
   Web of Science ®Google Scholar
• Bersani G, Iannitelli A, Fiore M, Angelucci F, Aloe L. Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders. Med Hypotheses. 2000;55(3):199–207.
   Web of Science ®Google Scholar
• Angelucci F, Mathe AA, Aloe L. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res. 2004;146:151–165.
   PubMed Web of Science ®Google Scholar
• Branchi I, D’Andrea I, Fiore M, Di Fausto V, Aloe L, Alleva E. Early social enrichment shapes social behavior and nerve growth factor and brain-derived neurotrophic factor levels in the adult mouse brain. Biol Psychiatry. 2006;60(7):690–696.
   PubMed Web of Science ®Google Scholar
• Zhu SW, Yee BK, Nyffeler M, Winblad B, Feldon J, Mohammed AH. Influence of differential housing on emotional behaviour and neurotrophin levels in mice. Behav Brain Res. 2006;169(1):10–20.
   Web of Science ®Google Scholar
• Castren E. Neurotrophins and psychiatric disorders. Handb Exp Pharmacol. 2014;220:461–479.
   PubMedGoogle Scholar
• Archer T, Oscar-Berman M, Blum K, Gold M. Epigenetic modulation of mood disorders. J Genet Syndr Gene Ther. 2013;4(120):1000120.
   Google Scholar
• Benedetti F, Serretti A, Colombo C, Lorenzi C, Tubazio V, Smeraldi E. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett. 2004;368(2):123–126.
   Web of Science ®Google Scholar
• Chen YW, Lin PY, Tu KY, Cheng YS, Wu CK, Tseng PT. Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review. Neuropsychiatr Dis Treat. 2015;11:925–933.
   PubMed Web of Science ®Google Scholar
• Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008;11(8):1169–1180.
   PubMed Web of Science ®Google Scholar
• Lang UE, Hellweg R, Sander T, Gallinat J. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry. 2009;14(2):120–122.
   PubMed Web of Science ®Google Scholar
• Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003;112(2):257–269.
   PubMed Web of Science ®Google Scholar
• Sklar P, Gabriel SB, McInnis MG, et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry. 2002;7(6):579–593.
   PubMed Web of Science ®Google Scholar
• Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ. Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology. 2003;48(4):186–189.
   PubMed Web of Science ®Google Scholar
• Jiang X, Xu K, Hoberman J, et al. BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology. 2005;30(7):1353–1361.
   PubMed Web of Science ®Google Scholar
• Zakharyan R, Atshemyan S, Gevorgyan A, Boyajyan A. Nerve growth factor and its receptor in schizophrenia. BBA Clin. 2014;1:24–29.
   Google Scholar
• Lang UE, Hellweg R, Bajbouj M, Gaus V, Sander T, Gallinat J. Gender-dependent association of a functional NGF polymorphism with anxiety-related personality traits. Pharmacopsychiatry. 2008; 41(5):196–199.
   Web of Science ®Google Scholar
• Chang CC, Fang WH, Chang HA, Chen TY, Huang SY. Sex-specific association between nerve growth factor polymorphism and cardiac vagal modulation. Psychosom Med. 2014;76(8):638–643.
   Web of Science ®Google Scholar
• Bersani G, Iannitelli A, Massoni E, et al. Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects. Int J Immunopathol Pharmacol. 2004;17(3):367–372.
   Web of Science ®Google Scholar
• Curtis GC. Psychiatry’s need for research in chronobiology. Int J Chronobiol. 1973;1(1):8–10.
   Google Scholar
• Benedetti F, Barbini B, Colombo C, Smeraldi E. Chronotherapeutics in a psychiatric ward. Sleep Med Rev. 2007;11(6):509–522.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Associations. Diagnostic and Statistical Manual of Mental of Mental Disorders. 5th ed. Washington, DC/London, England: American Psychiatric Publishing; 2013.
   Google Scholar
• LeGates TA, Fernandez DC, Hattar S. Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci. 2014; 15(7):443–454.
   PubMed Web of Science ®Google Scholar
• LeGates TA, Altimus CM, Wang H, et al. Aberrant light directly impairs mood and learning through melanopsin-expressing neurons. Nature. 2012;491(7425):594–598.
   PubMed Web of Science ®Google Scholar
• Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression. 2nd ed. New York: Oxford University Press; 2012.
   Google Scholar
• Eagles JM. The relationship between mood and daily hours of sunlight in rapid cycling bipolar illness. Biol Psychiatry. 1994;36(6):422–424.
   PubMed Web of Science ®Google Scholar
• Friedman E, Gyulai L, Bhargava M, et al. Seasonal changes in clinical status in bipolar disorder: a prospective study in 1000 STEP-BD patients. Acta Psychiatr Scand. 2006;113(6):510–517.
   Web of Science ®Google Scholar
• Germain A, Frank E. Chronobiology of the core symptoms of depression. Medicographia. 2008;30(1):30–34.
   Google Scholar
• Bersani G, Bersani FS, Prinzivalli E, et al. Premorbid circadian profile of patients with major depression and panic disorder. Riv Psichiatr. 2012;47(5):407–412.
   Web of Science ®Google Scholar
• Souêtre E, Salvati E, Belugou JL, et al. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res. 1989;28(3):263–278.
   PubMed Web of Science ®Google Scholar
• Koenigsberg HW, Teicher MH, Mitropoulou V, et al. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res. 2004;38(5):503–511.
   Web of Science ®Google Scholar
• Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry. 1984;19(8):1215–1228.
   PubMed Web of Science ®Google Scholar
• Tsuno N, Besset A, Ritchie K. Sleep and depression. J Clin Psychiatry. 2005;66(10):1254–1269.
   PubMed Web of Science ®Google Scholar
• Riemann D, Berger M, Voderholzer U. Sleep and depression – results from psychobiological studies: an overview. Biol Psychol. 2001; 57(1–3):67–103.
   PubMed Web of Science ®Google Scholar
• Quartini A, Anastasia A, Bersani FS, et al. Changes in dream experience in relation with antidepressant escitalopram treatment in depressed female patients: a preliminary study. Riv Psichiatr. 2014; 49(4):187–191.
   Web of Science ®Google Scholar
• Freud D. Il Sogno. Torino: Bollati Boringhieri; 1990:4.42.
   Google Scholar
• Buysse DJ, Nofzinger EA, Germain A, et al. Regional brain glucose metabolism during morning and evening wakefulness in humans: preliminary findings. Sleep. 2004;27(7):1245–1254.
   Web of Science ®Google Scholar
• Wolff EA 3rd, Putnam FW, Post RM. Motor activity and affective illness. The relationship of amplitude and temporal distribution to changes in affective state. Arch Gen Psychiatry. 1985;42(3):288–294.
   Web of Science ®Google Scholar
• Moffoot AP, O’Carroll RE, Bennie J, et al. Diurnal variation of mood and neuropsychological function in major depression with melancholia. J Affect Disord. 1994;32(4):257–269.
   Web of Science ®Google Scholar
• Ohdo S. Chronopharmaceutics: pharmaceutics focused on biological rhythm. Biol Pharm Bull. 2010;33(2):159–167.
   Web of Science ®Google Scholar
• Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol. 2007;47:593–628.
   PubMed Web of Science ®Google Scholar
• Sukumaran S, Almon RR, DuBois DC, Jusko WJ. Circadian rhythms in gene expression: relationship to physiology, disease, drug disposition and drug action. Adv Drug Deliv Rev. 2010;62(9–10):904–917.
   PubMed Web of Science ®Google Scholar
• Nagayama H. Influences of biological rhythms on the effects of psychotropic drugs. Psychosom Med. 1999;61(5):618–629.
   Web of Science ®Google Scholar
• Philipp M, Marneros A. Chronobiology and its implications for pharmacotherapy of endogenous depression. Pharmakopsychiatr Neuropsychopharmakol. 1978;11(5):235–240.
   Google Scholar
• Nagayama H, Nagano K, Ikezaki A, Tashiro T. Double-blind study of the chronopharmacotherapy of depression. Chronobiol Int. 1991;8(3):203–209.
   Web of Science ®Google Scholar
• Nakano S, Hollister LE. No circadian effect on nortriptyline kinetics in man. Clin Pharmacol Ther. 1978;23(2):199–203.
   Web of Science ®Google Scholar
• Usher RW, Beasley CM Jr, Bosomworth JC. Efficacy and safety of morning versus evening fluoxetine administration. J Clin Psychiatry. 1991;52(3):134–136.
   Web of Science ®Google Scholar
• Li JZ, Bunney BG, Meng F, et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A. 2013;110(24):9950–9955.
   Web of Science ®Google Scholar
• Czeisler CA, Dijk DK. Use of bright light to treat maladaptation to night shift work and circadian rhythm sleep disorder. J Sleep Res. 1995;4(52):70–73.
   Google Scholar
• Wirz-Justice A. From the basic neuroscience of circadian clock function to light therapy for depression: on the emergence of chronotherapeutics. J Affect Disord. 2009;116(3):159–160.
   Web of Science ®Google Scholar
• Benedetti F. Antidepressant chronotherapeutics for bipolar depression. Dialogues Clin Neurosci. 2012;14(4):401–411.
   PubMedGoogle Scholar
• Wirz-Justice A, Terman M. Chronotherapeutics (light and wake therapy) as a class of interventions for affective disorders. Handb Clin Neurol. 2012;106:697–713.
   Google Scholar
• Echizenya M, Suda H, Takeshima M, Inomata Y, Shimizu T. Total sleep deprivation followed by sleep phase advance and bright light therapy in drug-resistant mood disorders. J Affect Disord. 2013;144(1–2):28–33.
   PubMed Web of Science ®Google Scholar
• Sahlem GL, Kalivas B, Fox JB, et al. Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study. J Psychiatr Res. 2014;59:101–107.
   PubMed Web of Science ®Google Scholar
• Wisor JP, O’Hara BF, Terao A, et al. A role for cryptochromes in sleep regulation. BMC Neurosci. 2002;3:20.
   PubMed Web of Science ®Google Scholar
• Wisor JP, Pasumarthi RK, Gerashchenko D, et al. Sleep deprivation effects on circadian clock gene expression in the cerebral cortex parallel electroencephalographic differences among mouse strains. J Neurosci. 2008;28(28):7193–7201.
   Web of Science ®Google Scholar
• Takimoto M, Hamada A, Tomoda A, et al. Daily expression of clock genes in whole blood cells in healthy subjects and a patient with circadian rhythm sleep disorder. Am J Physiol Regul Integr Comp Physiol. 2005;289(5):R1273–R1279.
   Web of Science ®Google Scholar
• Zhu Y, Fu A, Hoffman AE, et al. Advanced sleep schedules affect circadian gene expression in young adults with delayed sleep schedules. Sleep Med. 2013;14(5):449–455.
   Web of Science ®Google Scholar
• Uz T, Ahmed R, Akhisaroglu M, et al. Effect of fluoxetine and cocaine on the expression of clock genes in the mouse hippocampus and striatum. Neuroscience. 2005;134(4):1309–1316.
   PubMed Web of Science ®Google Scholar
• Prouse J, Braselton J, Reynolds L. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biol Psychiatry. 2006;60(8):896–899.
   Web of Science ®Google Scholar
• Millan MJ, Gobert A, Lejeune F, et al. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther. 2003;306(3):954–964.
   PubMed Web of Science ®Google Scholar
• Bourin M, Mocaer E, Porsolt R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors. J Psychiatry Neurosci. 2004; 29(2):126–133.
   PubMed Web of Science ®Google Scholar
• Van Reeth O, Olivares E, Zhang Y, et al. Comparative effects of a melatonin agonist on the circadian system in mice and Syrian hamsters. Brain Res. 1997;762(1–2):185–194.
   PubMed Web of Science ®Google Scholar
• Bellet MM, Vawter MP, Bunney BG, Bunney WE, Sassone-Corsi P. Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS One. 2011;6(8):e23982.
   Web of Science ®Google Scholar
• Li SX, Liu LJ, Xu LZ, et al. Diurnal alterations in circadian genes and peptides in major depressive disorder before and after escitalopram treatment. Psychoneuroendocrinology. 2013;38(11):2789–2799.
   Web of Science ®Google Scholar
• LeSauter J, Silver R. Lithium lengthens the period of circadian rhythms in lesioned hamsters bearing SCN grafts. Biol Psychiatry. 1993;34(1–2):75–83.
   Web of Science ®Google Scholar
• Nagayama H. Chronic administration of imipramine and lithium changes the phase-angle relationship between the activity and core body temperature circadian rhythms in rats. Chronobiol Int. 1996;13(4):251–259.
   PubMed Web of Science ®Google Scholar
• Hickie IB, Naismith SL, Robillard R, Scott EM, Hermens DF. Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression. BMC Med. 2013;11:79.
   PubMed Web of Science ®Google Scholar
• Quiroz JA, Gould TD, Manji HK. Molecular effects of lithium. Mol Interv. 2004;4(5):259–272.
   PubMedGoogle Scholar
• Iitaka C, Miyazaki K, Akaike T, Ishida N. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem. 2005;280(33):29397–29402.
   Web of Science ®Google Scholar
• Bunney BG, Li JZ, Walsh DM, et al. Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder. Mol Psychiatry. 2015;20(1):48–55.
   PubMed Web of Science ®Google Scholar
• Chiu CT, Wang Z, Hunsberger JG, Chuang DM. Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev. 2013;65(1):105–142.
   PubMed Web of Science ®Google Scholar
• Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem. 2001;276(39):36734–36741.
   PubMed Web of Science ®Google Scholar
• Finkbeiner S. CREB couples neurotrophin signals to survival messages. Neuron. 2000;25(1):11–14.
   PubMed Web of Science ®Google Scholar
• Lim S, Moon M, Oh H, Kim HG, Kim SY, Oh MS. Ginger improves cognitive function via NGF-induced ERK/CREB activation in the hippocampus of the mouse. J Nutr Biochem. 2014;25(10):1058–1065.
   PubMed Web of Science ®Google Scholar
• Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol. 2001;65(4):391–426.
   PubMed Web of Science ®Google Scholar
• Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev. 2004; 45(2):104–114.
   PubMedGoogle Scholar
• Ricci V, Martinotti G, Gelfo F, et al. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology (Berl). 2011;215(1):143–148.
   Web of Science ®Google Scholar
• Ladea M, Bran M. Brain derived neurotrophic factor (BDNF) levels in depressed women treated with open-label escitalopram. Psychiatr Danub. 2013;25(2):128–132.
   Web of Science ®Google Scholar
• Ricken R, Adli M, Lange C, et al. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants. J Clin Psychopharmacol. 2013;33(6):806–809.
   Web of Science ®Google Scholar
• Giese M, Beck J, Brand S, et al. Fast BDNF serum level increase and diurnal BDNF oscillations are associated with therapeutic response after partial sleep deprivation. J Psychiatr Res. 2014;59:1–7.
   PubMed Web of Science ®Google Scholar
• Agnati LF, Barlow PW, BaluŠka F, et al. A new theoretical approach to the functional meaning of sleep and dreaming in humans based on the maintenance of ‘predictive psychic homeostasis’. Commun Integr Biol. 2011;4(6):640–654.
   PubMedGoogle Scholar
• Soumier A, Banasr M, Lortet S, et al. Mechanisms contributing to the phase-dependent regulation of neurogenesis by the novel antidepressant, agomelatine, in the adult rat hippocampus. Neuropsychopharmacology. 2009;34(11):2390–2403.
   PubMed Web of Science ®Google Scholar
• Schulte-Herbrüggen O, Fuchs E, Abumaria N, et al. Effects of escitalopram on the regulation of brain-derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress. J Neurosci Res. 2009;87(11):2551–2560.
   PubMed Web of Science ®Google Scholar
• Angelucci F, Aloe L, Jimenez-Vasquez P, Mathe AA. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int J Neuropsychopharmacol. 2003;6(3):225–231.
   PubMed Web of Science ®Google Scholar
• Gorgulu Y, Caliyurt O. Rapid antidepressant effects of sleep deprivation therapy correlates with serum BDNF changes in major depression. Brain Res Bull. 2009;80(3):158–162.
   PubMed Web of Science ®Google Scholar
• Molendijk ML, Haffmans JP, Bus BA, et al. Serum BDNF concentrations show strong seasonal variation and correlations with the amount of ambient sunlight. PLoS One. 2012;7(11):e48046.
   Web of Science ®Google Scholar
• Sei H, Saitoh D, Yamamoto K, Morita K, Morita Y. Differential effect of short-term REM sleep deprivation on NGF and BDNF protein levels in the rat brain. Brain Res. 2000;877(2):387–390.
   Web of Science ®Google Scholar
• Brandt JA, Churchill L, Guan Z, Fang J, Chen L, Krueger JM. Sleep deprivation but not a whisker trim increases nerve growth factor within barrel cortical neurons. Brain Res. 2001;898(1):105–112.
   Web of Science ®Google Scholar
• Hight K, Hallett H, Churchill L, De A, Boucher A, Krueger JM. Time of day differences in the number of cytokine-, neurotrophin- and NeuN-immunoreactive cells in the rat somatosensory or visual cortex. Brain Res. 2010;1337:32–40.
   PubMed Web of Science ®Google Scholar
• Begliuomini S, Lenzi E, Ninni F, et al. Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol. 2008;197(2):429–435.
   PubMed Web of Science ®Google Scholar
• Pluchino N, Cubeddu A, Begliuomini S, et al. Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmenopause. Hum Reprod. 2009;24(9):2303–2309.
   PubMed Web of Science ®Google Scholar
• Piccinni A, Marazziti D, Del Debbio A, et al. Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiol Int. 2008;25(5):819–826.
   PubMed Web of Science ®Google Scholar